Cargando…

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review

The efficacy of SARS-CoV-2 vaccination in patients with hematological malignancies (HM) appears limited due to disease and treatment-associated immune impairment. We conducted a systematic review of prospective studies published from 10/12/2021 onwards in medical databases to assess clinical efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piechotta, Vanessa, Mellinghoff, Sibylle C., Hirsch, Caroline, Brinkmann, Alice, Iannizzi, Claire, Kreuzberger, Nina, Adams, Anne, Monsef, Ina, Stemler, Jannik, Cornely, Oliver A., Bröckelmann, Paul J., Skoetz, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152308/ https://www.ncbi.nlm.nih.gov/pubmed/35641489 http://dx.doi.org/10.1038/s41408-022-00684-8

Ejemplares similares

The effectiveness of clinical guideline implementation strategies in oncology—a systematic review
por: Bora, Ana-Mihaela, et al.
Publicado: (2023)

Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review
por: Hausinger, Renate Ilona, et al.
Publicado: (2023)

Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper
por: Iannizzi, Claire, et al.
Publicado: (2022)

P586: POTENTIAL DRUG-DRUG INTERACTIONS OF ANTIFUNGAL PROPHYLAXIS AND MIDOSTAURIN IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA – CLINICAL IMPLICATIONS OF THERAPEUTIC DRUG MONITORING
por: Joisten, Carolin, et al.
Publicado: (2023)

Methods and guidance on conducting, reporting, publishing and appraising living systematic reviews: a scoping review protocol
por: Iannizzi, Claire, et al.
Publicado: (2021)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in CLL: how often is enough?
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)

Immunogenic Cell Death in Hematological Malignancy Therapy
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
por: Stemler, Jannik, et al.
Publicado: (2020)

Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis
por: Malin, Jakob J, et al.
Publicado: (2023)

Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect
por: Schumacher, Sofie, et al.
Publicado: (2020)

EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence
por: Stemler, Jannik, et al.
Publicado: (2021)

Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2018)

Metadata Correction: Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2019)

The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review
por: Salek, Sam, et al.
Publicado: (2022)

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
por: Rieger, C T, et al.
Publicado: (2018)

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Stemler, Jannik, et al.
Publicado: (2023)

Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
por: Brinkmann, K, et al.
Publicado: (2014)

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)

Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
por: Stemler, Jannik, et al.
Publicado: (2020)

Harmonized procedure coding system for surgical procedures and analysis of surgical site infections (SSI) of five European countries
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022
por: Stemler, Jannik, et al.
Publicado: (2022)

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
por: Neuhann, Julia M., et al.
Publicado: (2022)

P1557: A STUDY ON THE IMMUNOGENICITY OF COVID-19 VACCINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCY
por: Mesina, Flordeluna, et al.
Publicado: (2023)

Gender differences of health literacy in persons with a migration background: a systematic review and meta-analysis
por: Chakraverty, Digo, et al.
Publicado: (2022)

Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis
por: Teh, Joanne S. K., et al.
Publicado: (2022)

Thermoresponsive Polypeptide Fused L‐Asparaginase with Mitigated Immunogenicity and Enhanced Efficacy in Treating Hematologic Malignancies
por: Zhang, Sanke, et al.
Publicado: (2023)

Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19
por: Meinberger, Denise, et al.
Publicado: (2021)

The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity
por: Keutmann, Matthias, et al.
Publicado: (2022)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology
por: Stemler, Jannik, et al.
Publicado: (2021)

Invasive Aspergillosis in Patients Treated With Ibrutinib
por: Fürstenau, Moritz, et al.
Publicado: (2020)

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2019)

Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic
por: Schumacher, Sofie, et al.
Publicado: (2023)

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
por: Ni, Bin, et al.
Publicado: (2022)

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies
por: Thookhamme, Chayapa, et al.
Publicado: (2023)

MicroRNAs in Autoimmunity and Hematological Malignancies
por: Marco, Mirco Di, et al.
Publicado: (2018)

Web-based, rapid and contactless management of ambulatory patients for SARS-CoV-2-testing
por: Stemler, Jannik, et al.
Publicado: (2021)

Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection
por: Pasikhova, Yanina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5l4758m8detu4fjud5eqrdptdr